Israeli medical company Dune Medical Devices inc., has received FDA approval for its MarginProbe device, which improves results of tumor removal in breast cancer patients. Dune Medical, which was founded in 2004, has raised $30 to date and says it will continue developing other devices for the medical market.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

AI Can Predict Future Heart Attacks By Analyzing CT Scans
October 01, 2023

Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023

Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023

Solar Panels On A Roll Certified As Safe For Use In US, Europe
September 28, 2023
Facebook comments